SCHEMBL1106659

SCHEMBL1106659

Nc1ncnc2c1nc(-c1ccccc1)n2[C@@H]1OC2CO[P@@](O)(=S)OC2[C@@H]1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.63
▸ ALDH1A1 P00352 1/20 0.63
▸ KMT2A Q03164 1/20 0.63
▸ PDE4A P27815 12/20 0.62
▸ PDE4B Q07343 12/20 0.62
▸ PDE4C Q08493 12/20 0.62
▸ PDE4D Q08499 12/20 0.62
▸ HSD17B10 Q99714 1/20 0.58
▸ GAPDH P04406 1/20 0.58
▸ NADK O95544 1/20 0.56
▸ RAPGEF3 O95398 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ HIF1A Q16665 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ PMP22 Q01453 1/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.55
▸ PRKACA P17612 1/20 0.55
▸ PRKACG P22612 1/20 0.55
▸ PRKACB P22694 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15906321 1.00 MEN1 (0.63) MEN1ALDH1A1KMT2APDE4APDE4B
SCHEMBL1135445 1.00 MEN1 (0.63) MEN1ALDH1A1KMT2APDE4APDE4B
SCHEMBL1106675 1.00 MEN1 (0.63) MEN1ALDH1A1KMT2APDE4APDE4B
SCHEMBL14034143 0.90 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DHSD17B10
SCHEMBL14030437 0.87 MEN1 (0.69) MEN1ALDH1A1KMT2APDE4APDE4B
SCHEMBL15906301 0.87 MEN1 (0.69) MEN1ALDH1A1KMT2APDE4APDE4B
SCHEMBL5150796 0.85 MEN1 (0.69) MEN1ALDH1A1KMT2APDE4APDE4B
SCHEMBL29379210 0.84 PDE4A (0.79) MEN1ALDH1A1KMT2APDE4APDE4B
SCHEMBL29358957 0.84 PDE4A (0.79) MEN1ALDH1A1KMT2APDE4APDE4B
SCHEMBL30237695 0.80 PDE4A (0.84) MEN1ALDH1A1KMT2APDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153609-B2 Purine nucleotide derivatives LAURAS AS (NO) 2012-04-10 — — US disclosed
US-20080293665-A1 Purine Nucleotide Derivatives LAURAS AS (NO) 2008-11-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293665-A1 Purine Nucleotide Derivatives CGAS, PDE8A, PDE7A MEN1 634/4885ALDH1A1 3225/4885KMT2A 2101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback